Stock Analysis
Solventum Corporation (SOLV) Stock Analysis
Solventum Corporation (SOLV) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
Solventum Corporation (SOLV) currently has an AIQ Score of 58/100, indicating a neutral setup. Quality is the strongest factor at 67/100. Momentum is the weakest current factor at 38/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
SOLV at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $81.33 |
| AIQ Score | 58/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Strong Sell |
| Market Cap | $15.75B |
| P/E Ratio (TTM) | 11.06 |
| Forward P/E | — |
| EPS (quarter ended 2026-06-30) | $0.53 |
| Revenue (quarter ended 2026-06-30) | $2.21B |
| Dividend Yield (TTM) | 0.00% |
| Beta | 0.67 |
| Volume | 1.07M |
| 52-week range | $62.38-$94.16 |
| RSI 14 | 39.55 |
| 50-Day SMA | $88.24 |
| 200-Day SMA | $78.36 |
| Analyst Price Target | $90.46 |
| Next Earnings | Nov 5, 2026 |
SOLVSolventum Corporation
Healthcare / Medical - Instruments & Supplies
Low Priority
Above Peers
Latest quote
- Momentum38
- Value67
- Quality67
- Risk resilience54
- Sentiment—
SOLV Stock Analysis Summary
Solventum Corporation (SOLV) currently has an AIQ Score of 58/100, indicating a neutral setup. Quality is the strongest factor at 67/100. Momentum is the weakest current factor at 38/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, SOLV has AIQ Score of 58/100 with Quality base of 67/100 and fading Momentum at 38/100. Wait for component alignment before adding exposure.
Quality (67/100) leads while Momentum (38/100) lags. This cross-factor spread creates entry timing uncertainty.
Healthcare · -2.67% stock move · SOLV classified in Medical - Instruments & Supplies.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is SOLV Bullish or Bearish Right Now?
SOLV currently has a neutral overall setup. Value is the strongest factor at 67/100, while Momentum is weakest at 38/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Quality is supportive at 67/100.
- - Analyst target implies +11.23% upside from the latest quote.
- - Momentum is weak at 38/100.
- - Technical consensus has more sell votes than buy votes (35 vs 5).
Current Consensus
SOLV's Technical Analysis Consensus is currently Strong Sell, with 5 buy, 5 neutral, and 35 sell votes. SOLV's 14-day RSI is 39.55, which places the stock in a weaker momentum range. SOLV's beta is 0.67, indicating lower market sensitivity than the broad market.
What Changed in SOLV?
The largest recent change in SOLV is Momentum moving down by 9.0 points over the available 7-day comparison window. Value remains the strongest visible factor.
What Would Change the SOLV Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
SOLV Decision Framework
Public evidence layers, setup checks, and risk context for Solventum Corporation.
Solventum Corporation (SOLV) Stock Analysis
Solventum Corporation has an AIQ Score of 58/100 in a Neutral regime. Value is strongest at 67/100. Beta is 0.7, below market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | SOLV is in a Neutral AIQ regime with score 58/100. |
| Signal Conflict | The primary conflict is that value leads at 67/100 while momentum lags at 38/100. |
| Factor Evidence | Momentum 38/100 · Value 67/100 · Quality 67/100 · Risk 54/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Value is the strongest factor at 67/100.
Momentum is 38/100 and RSI (14) is 39.6.
SOLV is in a Neutral regime at 58/100.
Risk factor is 54/100 with beta 0.7 and annual volatility 29.98%.
Current conflict: value leads at 67/100 while momentum lags at 38/100.
SOLV Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
SOLV Fundamentals
SOLV valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
SOLV Technical Analysis
SOLV technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
SOLV Stock Catalysts
Track SOLV earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
SOLV Dividend Analysis
SOLV dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
SOLV Financial Data
SOLV revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
SOLV Risk Analysis
SOLV volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
SOLV Stock News
SOLV stock news, market tone, recent headlines, and catalyst context.
SOLV vs Medical Devices Peers
Current peer cohort: SOLV · STE · SYK · TFX · TMDX. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| SOLV Current stock | 58/100 | 67/100 | 38/100 | 54/100 | 0.62 | 29.98% | Current |
| STE Steris | 63/100 | 48/100 | 83/100 | 71/100 | -0.1 | 26.00% | SOLV vs STE |
| SYK Stryker | 62/100 | 42/100 | 80/100 | 64/100 | -0.54 | 30.40% | SOLV vs SYK |
| TFX Teleflex | 61/100 | 61/100 | 84/100 | 67/100 | 0.35 | 39.71% | SOLV vs TFX |
| TMDX TransMedics | 39/100 | 32/100 | 23/100 | 32/100 | -0.99 | 57.13% | SOLV vs TMDX |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Oct 29, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts4 recent quarterly periods are available for review.
Checked Oct 31, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Jun 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching SOLV
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for SOLV
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
SOLV Stock FAQ
What is SOLV stock price today?
Solventum Corporation's current stock price is $81.33. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is SOLV bullish or bearish right now?
SOLV's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is SOLV's market cap?
SOLV's market cap is $15.75B based on the latest completed market-close snapshot from Oct 30, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is SOLV's current P/E ratio?
SOLV's current P/E ratio is 11.06 based on the latest completed market-close snapshot from Oct 30, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is SOLV's RSI?
SOLV's 14-day RSI is 39.55 based on the latest completed market-close snapshot from Oct 30, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is SOLV above its 50-day and 200-day moving averages?
SOLV is -5.30% from its 50-day SMA and 6.63% from its 200-day SMA based on the latest completed market-close snapshot from Oct 30, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is SOLV's next earnings date?
SOLV's next earnings date is currently listed as Nov 5, 2026. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does SOLV pay a dividend?
SOLV's dividend yield is 0.00% based on the latest completed market-close snapshot from Oct 30, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.